Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$357K Buy
987
+3
+0.3% +$1.03K 0.14% 80
2026
Q1
$346K Buy
984
+2
+0.2% +$713 0.15% 78
2025
Q4
$336K Buy
982
+2
+0.2% +$634 0.15% 80
2025
Q3
$290K Sell
980
-71
-7% -$20.6K 0.14% 84
2025
Q2
$308K Buy
1,051
+2
+0.2% +$567 0.16% 76
2025
Q1
$322K Hold
1,049
0.18% 71
2024
Q4
$273K Buy
1,049
+300
+40% +$89K 0.15% 79
2024
Q3
$238K Buy
749
+93
+14% +$30.4K 0.14% 85
2024
Q2
$205K Buy
+656
New +$193K 0.13% 85

Other funds holding AMGN

GEM Asset Management's AMGN Position: Q2 2026 in Review

GEM Asset Management increased its Amgen (AMGN) stake by 0.3% in Q2 2026, buying an estimated $1.03K and bringing the position to 987 shares worth $357K. The position accounts for 0.14% of the portfolio, ranked #80.

GEM Asset Management first reported a position in AMGN in Q2 2024 and has held it in 9 quarters since. 1,339 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • GEM Asset Management held 987 shares of Amgen worth $357K as of Q2 2026.
  • GEM Asset Management bought 3 Amgen shares in Q2 2026, an estimated $1.03K.
  • Amgen made up 0.14% of GEM Asset Management's portfolio in Q2 2026, its #80 holding.
  • GEM Asset Management first reported a position in Amgen in Q2 2024 and has held it in 9 quarters since.
  • 1,339 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on GEM Asset Management's 13F filing for Q2 2026, filed 21 Jul 2026.